What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Cancer
His scientific interests lie mostly in Immunology, Quinolinic acid, Dementia, Acquired immunodeficiency syndrome and Kynurenine pathway.
His work carried out in the field of Immunology brings together such families of science as Cerebrospinal fluid and Virology.
Bruce J. Brew has researched Quinolinic acid in several fields, including Neurotoxicity, Pathogenesis, Astrocyte, Pharmacology and Kynurenine.
His Dementia study integrates concerns from other disciplines, such as Viral disease, Opportunistic infection, HIV-associated neurocognitive disorder and Immunopathology.
The Acquired immunodeficiency syndrome study combines topics in areas such as Neurocognitive, Internal medicine, Incidence and Psychiatry.
His Kynurenine pathway research incorporates themes from Kynurenic acid, Cell biology, Microglia and Indoleamine 2,3-dioxygenase.
His most cited work include:
- Updated research nosology for HIV-associated neurocognitive disorders (1808 citations)
- The AIDS Dementia Complex (1319 citations)
- The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex (1098 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Immunology, Internal medicine, Neurocognitive, Acquired immunodeficiency syndrome and Dementia.
His Immunology study combines topics from a wide range of disciplines, such as Quinolinic acid, Cerebrospinal fluid and Central nervous system.
As a part of the same scientific family, he mostly works in the field of Quinolinic acid, focusing on Kynurenic acid and, on occasion, Kynurenine pathway.
His work deals with themes such as Gastroenterology, Endocrinology, Viral load and Oncology, which intersect with Internal medicine.
As part of one scientific family, Bruce J. Brew deals mainly with the area of Neurocognitive, narrowing it down to issues related to the Disease, and often Intensive care medicine.
Bruce J. Brew has included themes like Mental health, Neurology, Cognition and Pediatrics in his Acquired immunodeficiency syndrome study.
He most often published in these fields:
- Immunology (34.13%)
- Internal medicine (31.10%)
- Neurocognitive (30.45%)
What were the highlights of his more recent work (between 2017-2021)?
- Neurocognitive (30.45%)
- Internal medicine (31.10%)
- Cognition (6.70%)
In recent papers he was focusing on the following fields of study:
Bruce J. Brew mainly focuses on Neurocognitive, Internal medicine, Cognition, Immunology and HIV-associated neurocognitive disorder.
He combines subjects such as Dementia, Disease, Gerontology and Neuropsychology with his study of Neurocognitive.
His Acquired immunodeficiency syndrome research extends to the thematically linked field of Cognition.
In general Immunology, his work in BCL11B is often linked to Microvesicles linking many areas of study.
His study looks at the relationship between HIV-associated neurocognitive disorder and fields such as Psychiatry, as well as how they intersect with chemical problems.
His research investigates the connection with Quinolinic acid and areas like Excitotoxicity which intersect with concerns in Kynurenine pathway.
Between 2017 and 2021, his most popular works were:
- Chronic Meningitis Investigated via Metagenomic Next-Generation Sequencing. (98 citations)
- Chronic Meningitis Investigated via Metagenomic Next-Generation Sequencing. (98 citations)
- Effect of the Mediterranean diet on cognition and brain morphology and function: a systematic review of randomized controlled trials (53 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
Bruce J. Brew mostly deals with Internal medicine, Neurocognitive, Immunology, Randomized controlled trial and HIV-associated neurocognitive disorder.
His work in the fields of Internal medicine, such as Meta-analysis and Chronic meningitis, overlaps with other areas such as Metagenomics and DNA sequencing.
His Neurocognitive research is multidisciplinary, incorporating elements of Clinical trial, Neuropsychological test, Neuropsychology, Test performance and Pediatrics.
His Immunology research is multidisciplinary, incorporating perspectives in Neuropathic pain, Asymptomatic and Nerve growth factor.
His HIV-associated neurocognitive disorder research includes elements of Csf biomarkers, Cellular energy and BCL11B.
His research in Cerebrospinal fluid tackles topics such as Tau protein which are related to areas like Kynurenine pathway and Kynurenine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
